Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, forecasts, risk factors, and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A cross-society Delphi consensus statement on the new nomenclature of fatty liver disease. J Hepatol. 2023;79:1542–56.
Hagström H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD fulfill the MASLD criteria and the natural history of the disease is therefore identical. J Hepatol. 2024;80:e76–e77.
Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. Clinical profiles and mortality rates are similar in metabolic fatty liver disease and nonalcoholic fatty liver disease. J Hepatol. 2024;80:694–701.
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. Diagnosis and treatment of nonalcoholic fatty liver disease: practice guideline of the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57.
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces the features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367–378.e365.
Tao LX, Yang K, Huang FF, Liu XT, Li X, Luo YX, et al. Association between self-reported eating speed and metabolic syndrome in an adult population in Beijing: a cross-sectional study. BMC Public Health. 2018;18:855.
Garcidueñas-Fimbres TE, Paz-Graniel I, Nishi SK, Salas-Salvadó J, Babio N. Eating speed, eating frequency, and their associations with diet quality, obesity, and metabolic syndrome or its components. Nutrients. 2021;13:1687.
Barrea L, Vetrani C, Verde L, Napolitano B, Savastano S, Colao A, et al. “Forever young at the table”: metabolic effects of eating speed in obesity. J Transl Med. 2021;19:530.
Kolay E, Bykowska-Derda A, Abdulsamad S, Kaluzna M, Samarzewska K, Ruchala M, et al. Self-reported eating speed is associated with indicators of obesity in adults: a systematic review and meta-analysis. Public Health. 2021;9:1559.
Nanri A, Miyaji N, Kochi T, Eguchi M, Kabe I, Mizoue T. Eating speed and risk of metabolic syndrome in Japanese workers: the Furukawa Diet and Health Study. Nutrition. 2020;78:110962.
Saito Y, Kajiyama S, Nitta A, Miyawaki T, Matsumoto S, Ozasa N, et al. Fast eating has a significant impact on glycemic elevation in healthy women: randomized controlled crossover trial. Nutrients. 2020;12:2767.
Kudo A, Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, et al. Fast eating is a strong risk factor for new-onset diabetes in the Japanese general population. Sci Rep. 2019;9:8210.
Ozaki E, Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Muramatsu J, et al. Fast eating is associated with low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional study in Japan. Arch. Public Health. 2020;78:101.
Xia P, Zhao G, Ouyang J, Zhang Y, Guo Y, Wang J, et al. Investigating the relationship between the occurrence of fatty liver and lifestyle and diet. Chin J Behav Med Sci. 2005;14:1037–1038,1045.
Google Scholar
Chuyan WU, Zhongli J, Danjun HE. Investigation of lifestyle characteristics in patients with nonalcoholic fatty liver disease. Chin J Rehab Med. 2008;23:398–401.
Google Scholar
Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F. The lifestyle characteristics of nonalcoholic fatty liver disease in the PERSIAN Guilan cohort study. Open Access Maced J Med Sci. 2019;7:3313–8.
Lee S, Ko BJ, Gong Y, Han K, Lee A, Han BD, et al. Self-reported eating speed in association with nonalcoholic fatty liver disease in adults. Eur J Nutrition. 2016;55:327–33.
Takahashi F, Hashimoto Y, Kawano R, Kaji A, Sakai R, Kawate Y, et al. Fast eating is associated with nonalcoholic fatty liver disease in men but not women with type 2 diabetes: a cross-sectional study. Nutrients. 2020;12:2174.
Nishi T, Babazono A, Maeda T, Imatoh T, Une H. Effects of fasting and eating before bedtime on the development of nonalcoholic fatty liver disease. Population Health Manag. 2016;19:279–83.
Iwai K, Azuma T, Yonenaga T, Sasai Y, Watanabe K, Deguchi F, et al. Association between masticatory status and fatty liver diagnosed by liver-spleen attenuation ratio: a cross-sectional study. Int J Environ Res Public Health 2023;20:307.
Cao X, Gu Y, Bian S, Zhang Q, Meng G, Liu L, et al. Association between eating speed and newly diagnosed nonalcoholic fatty liver disease in the general population. Nutrition Res. 2020;80:78–88.
Xia MF, Sun XY, Zheng LL, Bi YF, Li Q, Sun LR, et al. Regional differences in susceptibility to nonalcoholic fatty liver disease in China. BMJ Open Diabetes Res Care. 2020;8:e001311.
Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real-time ultrasound in the diagnosis of fatty liver disease: a prospective study. J Hepatol. 2009;51:1061–7.
Argyrakopoulou, G, Simati S, Dimitriadis G, Kokkinos A. How important is eating speed for the physiological response to food intake, body weight control and glycaemia? Nutrients. 2020;12:1734.
Teo PS, van Dam RM, Whitton C, Tan LWL, Forde CG. Association between self-reported eating rate, energy intake and cardiovascular risk factors in a multi-ethnic Asian population. Nutrients. 2020;12:1080.
Kokkinos A, le Roux CW, Alexiadou K, Tentolouris N, Vincent RP, Kyriaki D, et al. Slow eating increases the postprandial response of the anorexigenic gut hormones peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 2010;95:333–7.
Hawton K, Ferriday D, Rogers P, Toner P, Brooks J, Holly J, et al. Slowing down: behavioral and physiological effects of reduced eating speed. Nutrients. 2019;11:50.
Karl JP, Young AJ, Rood JC, Montain SJ. Independent and combined effects of eating speed and energy density on energy intake, appetite, and gut hormones. Obesity (Silver Spring). 2013;21:E244–252.
Paz-Graniel I, Babio N, Mendez I, Salas-Salvado J. Association between eating speed and classic cardiovascular risk factors: a cross-sectional study. Nutrients. 2019;11:83.
Hurst Y, Fukuda H. Effects of changes in eating speed on obesity in patients with diabetes: a secondary analysis of longitudinal health survey data. BMJ Open. 2018;8:e019589.
Simon SL, Pan Z, Marden T, Zhou W, Ghosh T, Hossain D, et al. Body mass index and meal duration variability and association with eating speed. Front Nutr. 2022;9:941001.
Fagerberg P, Charmandari E, Diou C, Heimeier R, Karavidopoulou Y, Kassari P, et al. Fast eating is associated with increased BMI among high school students. Nutrients. 2021;13:880.
Faith MS, Diewald LK, Crabbe S, Burgess B, Berkowitz RI. Reduced eating pace (RePace) behavioral intervention for children at risk for or at risk of obesity: will the turtle win the race? Obesity (Silver Spring). 2019;27:121–9.
Zeng X, Cai L, Ma J, Ma Y, Jing J, Chen Y. Fast eating is positively associated with overall and abdominal obesity in Chinese children: a national survey. Sci Rep. 2018;8:14362.
Yuan SQ, Liu YM, Liang W, Li FF, Zeng Y, Liu YY, et al. Association between eating speed and metabolic syndrome: a systematic review and meta-analysis. Front Nutr. 2021;8:700936.
Galhardo J, Hunt LP, Lightman SL, Sabin MA, Bergh C, Sodersten P, et al. Normalization of eating behavior reduces body weight and improves gastrointestinal hormone secretion in overweight adolescents. J Clin Endocrinol Metab. 2012;97:E193–201.
Leeuwendaal NK, Cryan JF, Schellekens H. Gut peptides and the microbiome: focus on ghrelin. Curr Opin Endocrinol Diabetes Obes. 2021;28:243–52.
Liu Y, Zhong W, Li X, Shen F, Ma X, Yang Q, et al. Nutrition, gut microbiota and metabolites. Phenomics. 2023;3:268–84.
Wang SZ, Yu YJ, Adeli K. Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis. Microorganisms. 2020;8:.
Abu-Shanab A, Quigley EMM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology. 2010;7:691–701.
Li R, Sun XL, Li PZ, Li WZ, Zhao L, Zhu LY, et al. GLP-1-induced AMPK activation inhibits PARP-1 and promotes LXR-mediated ABCA1 expression to protect pancreatic beta cells from cholesterol-induced toxicity via cholesterol efflux. Front Cell Dev Biol. 2021;9:646113.
Tanaka N, Aoyama T, Kimura S, Gonzalez FJ. Targeted treatment of fatty liver disease by nuclear receptors. Pharmacol Ther. 2017;179:142–57.
Zhao R, Zhao L, Gao X, Yang F, Yang Y, Fang H, et al. Geographical differences in dietary patterns and their associations with overweight/obesity and hypertension in China: results from the China Nutrition and Health Surveillance (2015–2017). Nutrients. 2022;14:3949.
